Terms: = Ovarian cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Clinical Outcome
4 results:
1. Transcriptomic Characterization of Endometrioid, Clear Cell, and High-Grade Serous Epithelial ovarian Carcinoma.
Fridley BL; Dai J; Raghavan R; Li Q; Winham SJ; Hou X; Weroha SJ; Wang C; Kalli KR; Cunningham JM; Lawrenson K; Gayther SA; Goode EL
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1101-1109. PubMed ID: 29967001
[No Abstract] [Full Text] [Related]
2. The Associations of Genetic Variants in E-cadherin Gene With clinical outcome of Epithelial ovarian cancer.
Juan W; Shan K; Na W; Rong-Miao Z; Yan L
Int J Gynecol Cancer; 2016 Nov; 26(9):1601-1607. PubMed ID: 27779545
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients.
Chiang YC; Chang MC; Chen PJ; Wu MM; Hsieh CY; Cheng WF; Chen CA
Endocr Relat Cancer; 2013 Apr; 20(2):213-27. PubMed ID: 23329649
[TBL] [Abstract] [Full Text] [Related]
4. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Sharma A; Chosdol K; Kashyap S; Rai A; Pushker N; Bajaj MS; Ghose S
Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737
[TBL] [Abstract] [Full Text] [Related]